MapLight Therapeutics is Drug Discovery in United States that focus on transcriptomics platform business. Founded in 2018. They cover business area such as operator, novel treatment, brain disorder, proprietary optogenetic, a pipeline, target therapy, a spectrum, serious CNS disorder, professional, patient.
2018
( 6 years old in 2024 )
Transcriptomics Platform
-
501 2nd Street
San Francisco, CA 94107
United States
Private
operatornovel treatmentbrain disorderproprietary optogenetica pipelinetarget therapya spectrumserious CNS disorderprofessionalpatient
* We use standard office opening hours in near MapLight Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MapLight Therapeutics is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), MapLight Therapeutics business is focusing on Transcriptomics Platform.
MapLight Therapeutics headquarter office and corporate office address is located in 501 2nd Street San Francisco, CA 94107 United States.
MapLight Therapeutics was founded in United States.
In 2024, MapLight Therapeutics is currently focus on transcriptomics platform sector.
Above is snippet of Google Trends for "transcriptomics platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MapLight Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
